This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Infectious Diseases, Other  • Renal Diseases  • Dialysis  • Gastroenterology  • Liver/ Biliary Tract/ Pancreatic Diseases  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2009;301(15):1530-1535.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2009;58:189-194

1 figure omitted

In July 2008, the New York State Department of Health (NYSDOH) received reports of three hemodialysis patients seroconverting from anti-hepatitis C virus (HCV) negative to anti-HCV positive in a New York City hemodialysis unit during the preceding 6 months. NYSDOH conducted patient interviews and made multiple visits to the hemodialysis unit to observe hemodialysis treatments, assess infection control practices, evaluate HCV surveillance activities, review medical records, and conduct interviews with staff members. This report summarizes the results of that investigation, which found that six additional patients had HCV seroconversion during 2001-2008 and that the hemodialysis unit had numerous deficiencies in infection control policies, procedures, and training. Of the total of nine seroconversions, the sources for four HCV infections were identified phylogenetically and epidemiologically as four other patients in the unit. The unit's policy for routine patient testing for HCV infection was not in accordance with . . . [Full Text of this Article]

Epidemiologic Investigation



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?